Latest Updates

/ Moneycontrol Latest News / Strides Pharma rises 2% on USFDA approval for Ethosuximide softgel capsules

Strides Pharma rises 2% on USFDA approval for Ethosuximide softgel capsules

Strides Pharma rises 2% on USFDA approval for Ethosuximide softgel capsules The product will be manufactured at flagship facility in Bangalore and will be marketed by Strides Pharma Inc. in the US market.

from Moneycontrol Latest News https://ift.tt/2El6ncF
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();